Leading the Way in Life Science Technologies

GEN Exclusives

More »

Market and Technology Analysis

More »
Dec 4, 2013

Next-Generation Sequencing from Research to the Clinic

The opportunities for NGS as a diagnostic tool are immense.

Next-Generation Sequencing from Research to the Clinic

The FDA approved Illumina’s MiSeqDx platform for the clinic in late November. The report below shows how that approval may affect the market. [Select Biosciences]



Related content

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »